The Europe Protein Expression Market would witness market growth of 9.8% CAGR during the forecast period (2022-2028).
Within the realm of protein expression, the foreign DNA present within the recombinant variant construct may or may not be expressed after being transplanted into the host organism. In other words, the DNA may just be copied without being expressed or it may be translated and transcribed, leading to the production of a recombinant protein. It may be possible to modify the host organism in particular ways to enhance ectopic gene expression. To improve the translation some alterations may also be required.
The creation of recombinant proteins that can enter a cell is one of the main accomplishments. By focusing on intracellular mechanisms or by using therapeutic proteins to replace intracellularly active enzymes, such advancements open up entirely new possibilities in therapeutic medicine. Escherichia coli was used as the prokaryotic system for the first expression platform to be built. Other expression systems, such as those seen in yeast, algae, insects, and mammals, developed after this.
In academic institutions like universities or research institutes, the P4EU (Protein Production and Purification Partnership in Europe) is a network whose members work on diverse areas of protein expression, purification, and characterization using core technological platforms. With the original kick-off meeting taking place in Halle, Germany in February 2011, the P4EU was envisioned in 2010. It was founded with the goal of creating a platform for the sharing of data, expertise, and resources between core facility labs working on protein expression and purification, with a strong emphasis on customer service.
The Germany market dominated the Europe Protein Expression Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $319 Million by 2028. The UK market would generate a CAGR of 8.9% during (2022-2028). Additionally, The France market is showcasing a CAGR of 10.7% during (2022-2028).
Based on System, the market is segmented into Prokaryotic, Mammalian Cell, Insect Cell, Yeast, and Others. Based on Product, the market is segmented into Reagents, Competent Cells, Instruments, Services, and Others. Based on Application, the market is segmented into Therapeutic, Industrial, Research. Based on End-user, the market is segmented into Pharmaceutical & Biotechnological Companies, Academic Research, Contract Research Organizations, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck Group, New England BioLabs, Inc., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and LGC Biosearch Technologies.
Within the realm of protein expression, the foreign DNA present within the recombinant variant construct may or may not be expressed after being transplanted into the host organism. In other words, the DNA may just be copied without being expressed or it may be translated and transcribed, leading to the production of a recombinant protein. It may be possible to modify the host organism in particular ways to enhance ectopic gene expression. To improve the translation some alterations may also be required.
The creation of recombinant proteins that can enter a cell is one of the main accomplishments. By focusing on intracellular mechanisms or by using therapeutic proteins to replace intracellularly active enzymes, such advancements open up entirely new possibilities in therapeutic medicine. Escherichia coli was used as the prokaryotic system for the first expression platform to be built. Other expression systems, such as those seen in yeast, algae, insects, and mammals, developed after this.
In academic institutions like universities or research institutes, the P4EU (Protein Production and Purification Partnership in Europe) is a network whose members work on diverse areas of protein expression, purification, and characterization using core technological platforms. With the original kick-off meeting taking place in Halle, Germany in February 2011, the P4EU was envisioned in 2010. It was founded with the goal of creating a platform for the sharing of data, expertise, and resources between core facility labs working on protein expression and purification, with a strong emphasis on customer service.
The Germany market dominated the Europe Protein Expression Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $319 Million by 2028. The UK market would generate a CAGR of 8.9% during (2022-2028). Additionally, The France market is showcasing a CAGR of 10.7% during (2022-2028).
Based on System, the market is segmented into Prokaryotic, Mammalian Cell, Insect Cell, Yeast, and Others. Based on Product, the market is segmented into Reagents, Competent Cells, Instruments, Services, and Others. Based on Application, the market is segmented into Therapeutic, Industrial, Research. Based on End-user, the market is segmented into Pharmaceutical & Biotechnological Companies, Academic Research, Contract Research Organizations, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck Group, New England BioLabs, Inc., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and LGC Biosearch Technologies.
Scope of the Study
Market Segments Covered in the Report:
By System
- Prokaryotic
- Mammalian Cell
- Insect Cell
- Yeast
- Others
By Product
- Reagents
- Competent CellsInstruments
- Services
- Others
By Application
- Therapeutic
- Industrial
- Research
By End User
- Pharmaceutical & Biotechnological Companies
- Academic Research
- Contract Research Organizations
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Merck Group
- New England BioLabs, Inc.
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc. (Takara Holdings Inc.)
- Oxford Expression Technologies Ltd.
- LGC Biosearch Technologies
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Europe Protein Expression Market by System
Chapter 5. Europe Protein Expression Market by Product
Chapter 6. Europe Protein Expression Market by Application
Chapter 7. Europe Protein Expression Market by End-user
Chapter 8. Europe Protein Expression Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Merck Group
- New England BioLabs, Inc.
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc. (Takara Holdings Inc.)
- Oxford Expression Technologies Ltd.
- LGC Biosearch Technologies
Methodology
LOADING...
